NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Anti-climax: flibanserin flops before FDA

The AP reports:

“…members of the Food and Drug Administration’s reproductive drugs panel voted 11-0 that the drug’s benefits did not outweigh side effects, including fatigue, depression and fainting spells.

Flibanserin failed to increase sexual desire, as recorded by women in daily journals, in two company studies.

The FDA will make its own decision on the drug in coming months, though it generally follows the panel’s advise.”

When will we learn to put evidence before hype?

To wait until all the evidence is in before promoting something as “the female viagra” – as “the pink pill” that women have been waiting for?

Shame on the journalists who hyped this story leading up to the FDA panel’s vote. It resembled free advertising, free marketing, free buildup of demand for an unproven product.

And pity the poor consumers who heard about this every day and bought the hype.

When will we learn to be better evaluators of the evidence?

Addendum two hours after original post: many more good details in this story from

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Joseph Arpaia, MD

June 18, 2010 at 9:44 pm

It may have flopped but at least some media are spouting nonsense.
Here is a link to an NYT article which reports on the issue as if there is no doubt that female HSDD is a serious disorder. Terrible journalism.


June 19, 2010 at 9:12 am

i love it, im so glad this drug flopped they need to fire the greedy idiots at BI who tried to make up this disease state. I have an idea why not go after cures which BI has none (no long term money in that). good luck with your me too rat poison.